Dr. Kolios is Professor of Pharmacology in the Medical School at Democritus University of Thrace. He obtained his first degree in Medicine in 1980 and his PhD degree in 1992 from the Medical School at University of Athens. In 1998, he obtained his PhD degree in Pharmacology from the University of Bath, United Kingdom. In 1990, he finished his Specialization in Gastroenterology and he first worked as Registrar in Gastroenterology at Royal United Hospital, Bath, United Kingdom and then as Senior Registrar in Gastroenterology at Hippokration General Hospital, Athens, Greece. From 1998 till 2001, he worked as Consultant Gastroenterologist at Royal United Hospital, Bath, and as Senior Research Fellow in the Department of Pharmacology at University of Bath, United Kingdom. In 2001, he was appointed Assistant Professor of Gastroenterology in the School of Medicine at University of Crete and Visiting Professor in Pharmacology at University of Bath, United Kingdom. From 2008, he is Professor of Pharmacology and Head of the Laboratory of Pharmacology in the Medical School at Democritus University of Thrace and Head of the Laboratory of Clinical Pharmacology at University Hospital of Alexandroupolis, Greece. Professor George Kolios is Director of the Master’s Degree Program “Clinical Pharmacology and Therapeutics” that is organized by the Medical School of Democritus University of Thrace in collaboration with the Medical School of University of Crete. From 2008 till 2013, he was Member of the Scientific Board of Approvals of the Greek National Organization for Medicines. Professor George Kolios is an experienced Clinical Gastroenterologist, and he is also very productive research scientist, with an extensive work in the area of immuno-pharmacology, mucosal immunology and fibrosis, mainly focused on the intestinal inflammation and inflammatory bowel diseases. His work has demonstrated that the colonic epithelium could be a rich source of various inflammatory mediators, including chemokines and nitric oxide, which are involved in intestinal inflammation and fibrosis, and that these pro-inflammatory systems can be modified by cytokines derived by T-cell population. He has more than 70 publications in peer reviewed journals, which have been cited more than 1600 times.
Copyright © 2020 SUMMA Bio-Sciences - All Rights Reserved.